相关实验视频
Updated: Jan 8, 2026

06:33
Production of Human CRISPR-Engineered CAR-T Cells
Published on: March 15, 2021
14.3K
用CRISPR进行工程的微生物组:活体疗法彻底改变了血液癌症免疫疗法
Fang Cheng1, Hamed Soleimani Samarkhazan2, Yeganeh Khazaei3
1The Third Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450008, Henan, China. fangcheng@hactcm.edu.cn.
NPJ biofilms and microbiomes
|December 12, 2025
概括
用CRISPR设计的肠道微生物为治疗白血病等血液癌症提供了一种新的方法. 这些"活疗法"调节免疫力,向癌细胞,在临床前研究中显示有望减少毒性和改善结果.
科学领域:
- 血液瘤学 血液瘤学
- 微生物组的治疗方法
- 基因编辑CRISPR基因编辑
背景情况:
- 血液癌症 (白血病,淋巴瘤,骨髓瘤) 由于免疫逃避和毒性,往往会抵抗治疗.
- 目前的治疗方法在有效性和副作用方面面临局限性.
- 需要创新,有针对性的治疗策略至关重要.
研究的目的:
- 审查CRISPR工程肠道共生体的潜力,作为精确的精确性.
主要方法:
- 对免疫调节和直接瘤向的机械化策略的审查.
- 启用技术的分析:CRISPR变体,输送平台 (菌体/LNP),遗传电路和生物封闭.
- 治疗方式的讨论:免疫调节剂,瘤溶解有效载荷和抗癌代谢物的工程分泌.
主要成果:
- 临床前模型显示显著的抗瘤效应 (>60%的瘤减少在动物).
- 在受控环境中观察到CAR-T细胞功能的恢复.
- 克里斯普尔微生物组编辑证明了局部治疗的潜力,系统毒性降低.
结论:
- 通过CRISPR工程的肠道共生体代表了血液瘤学中的范式转变.
- 关键的挑战包括菌株稳定性,生物控制和非目标效应,并提出了杀死开关和AI优化等解决方案.
- 未来的方向包括在现场的菌体输送和多omics患者分层用于临床翻译.
相关概念视频
Microorganisms in Medicine and Therapeutics
914
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
914
CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
What is Genetic Engineering?
79.5K
Overview
79.5K

